Active Constituent in the Ethyl Acetate Extract Fraction of Terminalia bellirica Fruit Exhibits Antioxidation, Antifibrosis, and Proapoptosis Capabilities In Vitro
Open Access
- 9 May 2019
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-15
Abstract
Terminalia bellirica (Gaertn.) Roxb. fruit (TBF) is a widely planted traditional medicinal herb in Tibet. We aimed to determine the most active substance-enriched extract by comparing the in vitro antioxidant activities of different extract fractions of TBF that were subsequently extracted by petroleum ether, chloroform, ethyl acetate, and n-butanol after initial extraction by 95% ethanol. The main compounds of the ethyl acetate extract fraction (EF) were analyzed via HPLC-MS. Gallic acid (GA) was obtained from EF to determine in vitro antifibrotic activity based on the traditional usage of TBF. After HSC-T6 cells were incubated with GA, extracellular secreted levels of fibrosis-associated cytokines, such as collagen I, collagen III, TGF-β1, and hydroxyproline, were estimated by ELISA. Gene and protein expressions of PDGFR, CTGF, NF-κB, MMP-2, TIMP-1, TIMP-2, α-SMA, and the Bcl-2/Bax family were determined by quantitative PCR and western blot. The proapoptotic effect of GA was further investigated by annexin V-PI and TUNEL staining. These results indicate that EF has prominent in vitro antioxidant activity among four extract fractions, and its main component, GA, manifests antifibrosis activity and its potential mechanism of action includes inhibition of cytokine secretion and collagen synthesis, as well as proapoptosis of HSCs.Keywords
Funding Information
- Nanjing 321 Plan (2013A12011, 201103016, 2012BAI29B03)
- Commonweal Specialized Research Fund of China Agriculture (2013A12011, 201103016, 2012BAI29B03)
- Project of the National Twelve-Five Year Research Program of China (2013A12011, 201103016, 2012BAI29B03)
This publication has 50 references indexed in Scilit:
- Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in ratsPharmacognosy Research, 2011
- Polyphenolic compounds in the fruits of Egyptian medicinal plants (Terminalia bellerica, Terminalia chebula and Terminalia horrida): Characterization, quantitation and determination of antioxidant capacitiesPhytochemistry, 2010
- Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalisBMC Complementary and Alternative Medicine, 2010
- TGF-β1 Gene Silencing for Treating Liver FibrosisMolecular Pharmaceutics, 2009
- Comparative evaluation of Fe(III) reducing power-based antioxidant capacity assays in the presence of phenanthroline, batho-phenanthroline, tripyridyltriazine (FRAP), and ferricyanide reagentsTalanta, 2007
- Antioxidant activity of some algerian medicinal plants extracts containing phenolic compoundsFood Chemistry, 2006
- In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituentsPhytotherapy Research, 2005
- Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantationDigestive and Liver Disease, 2005
- Autocrine Overexpression of CTGF Maintains Fibrosis: RDA Analysis of Fibrosis Genes in Systemic SclerosisExperimental Cell Research, 2000
- New Anti-HIV-1, Antimalarial, and Antifungal Compounds from Terminalia bellericaJournal of Natural Products, 1997